Career Development Program
职业发展计划
基本信息
- 批准号:9134710
- 负责人:
- 金额:$ 4.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AwardCategoriesClinicalCollaborationsCutaneousDermatologyEquine muleEvaluationFacultyFellowshipFertilizationFundingGoalsGrantHematologyIndividualK-Series Research Career ProgramsLaboratoriesLeadLungMalignant NeoplasmsManuscriptsMentorsPeer ReviewPersonsPostdoctoral FellowProgress ReportsPublicationsPublishingResearchResearch PersonnelResourcesSECTM1 geneSkinSkin CancerStudy SectionSurgical OncologyTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of Healthabstractingcareercareer developmentexperiencefaculty mentorgraduate studentimpressioninnovationmelanomamembermid-career facultyoncologyprofessorprogramsprospective
项目摘要
This Career Development Program (CDP) will be used to prepare new Moffitt investigators at the rank of Assistant Member (Assistant Professor) or equivalent, particularly those already in the field of cutaneous malignancy research, or established Moffitt investigators at the rank of Associate Member (Associate Professor) or higher who are new to the field for careers in translational research of cutaneous malignancies. It will also ease their transition to independence as investigators either in the laboratory or as clinical trialists. The Moffitt Skin SPORE career development program will provide guidance, advice, mentoring, evaluation, and financial resources for continuing support for up to two faculty-level persons per year for 2-3 years each. All prospective projects have a mentor listed that is affiliated with the Skin SPORE or the Comprehensive Melanoma Research Center (CMRC) at Moffitt. The goal is to allow appropriate and motivated individuals to develop an independent research career in translational science focused on cutaneous malignancies. It is not meant as a training program for graduate students, postdoctoral fellows, or clinical fellows in hematology-oncology, surgical oncology or dermatology. In collaboration with the Moffitt Lung SPORE, one CDP award per year may be co-supported by the Skin SPORE, promoting cross-SPORE fertilization. Dr. James Mule will lead the CDP. He has extensive experience in mentoring, research and administration, including serving as a faculty mentor/preceptor on numerous K08, K12, K99/R00 and ACS Fellowship awards, as well as the PI of two T32 training grants. Applications will be reviewed by an Award Evaluation Committee chaired by Dr. Mule using a scientific standard similar to a NIH study section. Scores of 1 (exceptional) to 9 (poor) will be assigned for categories of Significance, Innovation, Scientific quality. Collaboration, and Potential for publication and external funding; with brief justifications and overall impression), using a review form that we had employed previously for use in the CMRC. Progress reports will be required from all funded CDP project applicants at the end of the first six months, and again at the end of the first year of funding. The progress reports will be reviewed by the Award Evaluation Committee consisting of the Moffitt Skin SPORE IAC (see above for a list of members) and ad hoc members. Published manuscripts, abstracts accepted and the potential for translational impact will constitute the most important criteria for renewal of funding for an additional year.
该职业发展计划(CDP)将用于准备助理成员(助理教授)或同等学历的新莫菲特研究人员,尤其是那些已经处于皮肤恶性肿瘤研究领域的人,或者是副教授(副教授)或更高级别的莫菲特研究人员,他们是新手,他们是新领域的职业生涯中新领域的皮肤恶性肿瘤。它还可以减轻他们在实验室或临床试验员中作为研究人员的独立过渡。 Moffitt Skin Spore职业发展计划将提供指导,建议,指导,评估和财务资源,以每年2 - 3年为2 - 3年的每年多达两名教职员工提供支持。所有前瞻性项目均列出了与莫菲特(Moffitt)的皮肤孢子或综合黑色素瘤研究中心(CMRC)相关的导师。目的是允许适当有动力的人在转化科学领域发展独立的研究职业,这些研究专注于皮肤恶性肿瘤。这并不意味着作为研究生,博士后研究员或血液肿瘤,外科肿瘤学或皮肤病学的临床研究员的培训计划。与莫菲特肺孢子合作,每年可能由皮肤孢子共同支持一个CDP奖,从而促进跨孢子的施肥。 James Mule博士将领导CDP。他在指导,研究和行政管理方面拥有丰富的经验,包括在许多K08,K12,K99/R00和ACS奖学金奖项以及两项T32培训赠款的PI中担任教师/受体。申请将由Mule博士主持的奖励评估委员会使用与NIH研究部分类似的科学标准进行审查。将分配1(差)为1(差)的分数(穷人)的分数将分配给重要性,创新,科学质量的类别。协作,以及出版和外部资金的潜力;有了简短的理由和整体印象),使用我们以前在CMRC中使用的审查表格。在头六个月结束时,以及第一年的资金结束时,所有资助的CDP项目申请人都需要进行进度报告。该进度报告将由奖励评估委员会审查,该委员会由Moffitt Skin Spore IAC组成(请参阅上文列表)和临时成员。已发表的手稿,被接受的摘要和转化影响的潜力将构成额外续签资金的最重要标准。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES J. MULE其他文献
JAMES J. MULE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES J. MULE', 18)}}的其他基金
Use of Human Dendritic Cells & Chemokines to Enhance Immune Response to Cancer
人类树突状细胞的用途
- 批准号:
7039735 - 财政年份:2004
- 资助金额:
$ 4.86万 - 项目类别:
RESEARCH TRAINING IN TRANSLATIONAL TUMOR IMMUNOLOGY
转化肿瘤免疫学研究培训
- 批准号:
6498060 - 财政年份:2001
- 资助金额:
$ 4.86万 - 项目类别:
RESEARCH TRAINING IN TRANSLATIONAL TUMOR IMMUNOLOGY
转化肿瘤免疫学研究培训
- 批准号:
6628504 - 财政年份:2001
- 资助金额:
$ 4.86万 - 项目类别:
RESEARCH TRAINING IN TRANSLATIONAL TUMOR IMMUNOLOGY
转化肿瘤免疫学研究培训
- 批准号:
6215924 - 财政年份:2001
- 资助金额:
$ 4.86万 - 项目类别:
DIRECT INTRATUMORAL ADMINISTRATION OF DENDRITIC CELLS
树突状细胞直接瘤内给药
- 批准号:
6545183 - 财政年份:2000
- 资助金额:
$ 4.86万 - 项目类别:
相似国自然基金
天疱疮慢性皮损异位淋巴结构支持类别转换后的致病性抗体分泌引起治疗抵抗
- 批准号:82304001
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
缜密感知导向的类别监督协同显著物体检测算法研究
- 批准号:62301451
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于全局学习的高光谱影像多类别变化检测方法研究
- 批准号:62301054
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多中心类别不平衡半监督医学影像分割及其在预后应用的方法研究
- 批准号:62306254
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MTMR3调控生发中心B细胞反应及IgA抗体类别转换参与IgA肾病的机制和干预研究
- 批准号:82370709
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
- 批准号:
10661301 - 财政年份:2023
- 资助金额:
$ 4.86万 - 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:
10663605 - 财政年份:2023
- 资助金额:
$ 4.86万 - 项目类别:
Modification and Pilot Testing of The Capacity cOaching And exerCise after Hospitalization for Heart Failure (COACH-HF) Intervention
心力衰竭住院后能力训练和锻炼(COACH-HF)干预措施的修改和试点测试
- 批准号:
10539371 - 财政年份:2023
- 资助金额:
$ 4.86万 - 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 4.86万 - 项目类别: